Adding everolimus to CNI after #livertransplantation lowers cancer risk and remains cost-effective, despite a higher infection risk. #TXPforAll #Transplantation #Immunosuppression tinyurl.com/4xyjydya

@TransplantJrnl Important tradeoff. Balancing reduced cancer risk with infection management highlights the need for tailored immunosuppression strategies post-transplant.